Dipyridamole echocardiography in essential hypertensive patients with chest pain.
- 1 September 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 12 (3), 238-243
- https://doi.org/10.1161/01.hyp.12.3.238
Abstract
The exercise-electrocardiography test shows limited feasibility and diagnostic accuracy for the noninvasive detection of coronary artery disease in hypertensive patients. Recently, the dipyridamole-echocardiography test (two-dimensional echocardiographic monitoring with dipyridamole infusion, up to 0.84 mg/kg over 10 minutes) has been proposed as an exercise-independent method for the diagnosis of coronary artery disease. The diagnostic usefulness of the exercise-electrocardiography test and the dipyridamole-echocardiography test was evaluated in 63 consecutive inpatients with history of chest pain, essential hypertension, and no previous myocardial infarction. The criterion of positivity for the exercise-electrocardiography test was a horizontal or downsloping ST segment shift exceeding 0.1 mV and for the dipyridamole-echocardiography test, a transient dyssynergy of contraction. Fifteen patients could not perform a diagnostic exercise-electrocardiography test because of an inability to exercise adequately (two patients), severe hypertension in spite of full antihypertensive therapy (six patients), or excessive blood pressure rise at the first step of the exercise-electrocardiography test (seven patients). Five patients could not perform the dipyridamole-echocardiography test because of a poor acoustic window. The overall feasibility was 76% for the exercise-electrocardiography test and 92% for the dipyridamole-echocardiography test (p less than 0.05). All 43 patients who performed both tests underwent coronary angiography; 30 had significant coronary artery disease (greater than 70% lumen reduction of at least 1 major coronary vessel). Sensitivity was 67% for both the exercise-electrocardiography test and the dipyridamole-echocardiography test (p = NS); specificity was 46% for the exercise-electrocardiography test and 92% for the dipyridamole-echocardiography test (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 14 references indexed in Scilit:
- Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome XThe American Journal of Cardiology, 1987
- Thallium-201 stress imaging in hypertensive patients.Hypertension, 1987
- Comparison of the high-dose dipyridamole-echocardiography test and exercise two-dimensional echocardiography for diagnosis of coronary artery diseaseThe American Journal of Cardiology, 1987
- Dipyridamole-echocardiography test in effort angina pectorisThe American Journal of Cardiology, 1985
- Exercise Radionuclide Ventriculographic Responses in Hypertensive Patients with Chest PainNew England Journal of Medicine, 1984
- Noninvasive detection and localization of coronary stenoses in patients: Comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imagingAmerican Heart Journal, 1982
- Assessment of Diagnostic Value of Dipyridamole Testing in Angina PectorisClinical Cardiology, 1982
- Dipyridamole Test in Angina Pectoris: Diagnostic Value and Pathophysiological ImplicationsJMIR AI, 1981
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatationThe American Journal of Cardiology, 1978
- Ein neuer pharmakologischer Test zur Diagnose der Koronarinsuffizienz*Deutsche Medizinische Wochenschrift (1946), 1976